Sen. Bonoff on Marriage Amendment: 'I Am Both Frustrated and Saddened' Patch.com I am both frustrated and saddened by this ill-timed effort. I am frustrated that we would use one of the last two weeks of the legislative session to debate a controversial social issue that ultimately serves to marginalize one group of people and ... |
Monday, May 16, 2011
Sen. Bonoff on Marriage Amendment: 'I Am Both Frustrated and Saddened' - Patch.com
Saturday, May 14, 2011
Job for junkies? Newspaper sparks controversy after advertising for marijuana ... - Daily Mail
Daily Mail | Job for junkies? Newspaper sparks controversy after advertising for marijuana ... Daily Mail By Daily Mail Reporter As jobs adverts go, it is one of the more controversial. Which might explain why the response has been stone cold. Southern Arizona local newspaper the Tuscon Weekly has come under fire after advertising for a medical marijuana ... |
Thursday, May 12, 2011
Man to be arraigned in nonprofit fraud - Boston Business Journal:
William O’Brien, 58, of Framingham is chargedf with 11 counts of larcenyover $250, two count s of larceny by continuous scheme and five counts of failurw to file income tax returns. In Octobedr 2008, the AG’s office launchec an investigationafter O’Brien’s alleged activities were reported by the nonprofit organization, which was not identified. O’Brien had been hire d by the nonprofit to handle variouasaccounting chores. The nonprofit eventually discoveredthat O’Briehn had allegedly been diverting payments from the corporatde account of the nonprofit’s account, to another account in his name.
O’Briem allegedly used the moneuy for his ownpersonal use, including to buyinbg items such as tickets to sporting events. He is set to be arraignes in Middlesex Superior Courtthis week.
Monday, May 9, 2011
Crescent files Chapter 11, replaces CEO - Phoenix Business Journal:
The moves are part of an effor to cutthe company’s debt and reworki its capital structures, the Charlotte, N.C.-basefd developer says. and some of its subsidiarie have filed voluntary Chapter 11 petitionse in the in the Western Districtrof Texas, Austin Division. Crescent also announced today thatArthufr Fields, the company’s chief executive has retired, effective immediately. He will continuee to work in anadvisory capacity. Crescent had been strugglintg to refinancea $1.2 billion with payment due in full by Septemberr 2012. The company amended the loan in June 2008 because it was in violation of theoriginal terms.
Before the Chapter 11 Crescent faced paymentsof $50 million by the end of this $75 million in 2010 and $100 million in 2011 on its The company, which has developerd more than 1 million squars feet of office space in Cool Springe since the 1990s, has been facing locall troubles, too. Pat Emery, Crescent’s long-time vice president and regional managerin Tennessee, left the compangy last month. And the developer’ss Crescent’s Greenway One, a $33 million, 168,000-square-foot building near completion onCarothers Parkway, has been boardedd up for months as contractors filed millions of dollars in liens against it.
Another similarly sizedd Crescent project next to it is about 90 percenrt vacant a year afterbein built. The company says it plans to continuwe businesses without any significant interruption during Crescent has obtaineda debtor-in-possession financing facility of $110 millio from a group of its existing which will provide funds so it can continuew operating. Andrew Hede will replace Fieldse as CEO and will be charged with leadingthe Hede, a managing directotr with LLC, has more than 15 years of financial restructuring and business experience.
“We have been in activew discussions with our lenders and othef stakeholders as we work toward an agreemengt that will bring our capital structure in line with the currenteconomic environment,” Hede says in a “Those discussions are and we are pleasee with the ongoing supporr we have received from our We intend to reacnh an agreement on our new capitall structure and emerge from bankruptcy
Saturday, May 7, 2011
Bream fishing perfect introduction for children - Online Athens
Bream fishing perfect introduction for children Online Athens http://images.morris.com/images/athens/mdControlled/cms/2011/05/04/824173254.jpg Special || Alvin Richardson poses with his daughter Lucy, who is a senior at UGA. Alvin Richardson poses with his daughter Lucy ... |
Thursday, May 5, 2011
Maryland may sue company over well accident - Pittsburgh Post Gazette
Maryland may sue company over well accident Pittsburgh Post Gazette HARRISBURG -- As state and federal officials continue their inquiries into last month's gas well accident in Bradford County, officials in Maryland are upset over what they fear could be flowing downstream ... |
Monday, May 2, 2011
Xanodyne Pharmaceuticals, Inc. Company Profile | Company Information
Xanodyne Pharmaceuticals is a privately-owned company backedr by some of the foremost privatd capital investorsin healthcare. Although a youn g company, Xanodyne has already established itselfd as a strong and competengt entity in the branded specialtuypharmaceutical industry. Xanodyne Pharmacal, Inc. was founded in July of 2001 in the Greate Cincinnati area byRoger Griggs, Chairmam of Union Springs LLC, a privatde equity group that focuses exclusively on investments in the life sciencexs sector, and Dr. Gilberft Gonzales, a neurologist and pain management Sinceits inception, Xanodyne has set a rapif pace of growth, development and acquisitions.
In 2001, it acquired Drug Enhancement Company of Americ aLLC (DECA), a privately held pharmaceutical productg development company. This acquisition not only increased the numberof near-termj pharmaceutical development projects, which complemented Xanodyne's strategic direction, but it also broughyt expertise and talented employeesz from DECA to Xanodyne. In earl 2004, Xanodyne Pharmacal, Inc. merged with Indianapolis-based Integritty Pharmaceuticals, Inc., (a womens health specialty company) with the newlyy merged company being renamedXanodyne Pharmaceuticals, Inc. In July of Xanodyne completed a transaction to acquirre most of the assetsof aaiPharma's pharmaceuticals division.
The deal value was in excessd of $200 million in cash...